CMS announced on April 21 st that they would extend the timeline for the temporary GLP-1 Bridge model through the end of December 2027, providing 18 months of coverage
The FDA approved tirzepatide in May 2022 under the brand name Mounjaro for type 2 diabetes management, and in November 2023 under the brand name Zepbound for chronic weight management in adults meeting specific BMI criteria
Glutathione peroxidase 3 serum levels and GPX3 gene polymorphisms in subjects with metabolic syndrome
Disclaimer: If you have a pre-existing medical condition like type 1 diabetes, are pregnant or breastfeeding at the time, or have had previous allergic reactions to weight loss medications, then this treatment is not advisable for you
The Injectable L-Carnitine You Need, The Quality You Trust Injectable L-Carnitine is widely referenced in research and performance-focused protocols where precision, absorption, and consistency matter
This treatment is loaded with IV fluids, electrolytes, B12, B-complex vitamins, vitamin C, glutathione, and biotin to help you look and feel your best